Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

Background: Elevated soluble urokinase plasminogen activator receptor (suPAR) is highly associated with increased risk of diabetic complications. Dapagliflozin is a drug inhibiting the sodium-glucose co-transporter 2 in the kidney to decrease blood glucose, while also decreasing risk of kidney disea...

Full description

Saved in:
Bibliographic Details
Main Authors: Viktor Rotbain Curovic (Author), Morten B. Houlind (Author), Tine W. Hansen (Author), Jesper Eugen-Olsen (Author), Jens Christian Laursen (Author), Mie K. Eickhoff (Author), Frederik Persson (Author), Peter Rossing (Author)
Format: Book
Published: Frontiers Media S.A., 2022-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items